Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-28

FDA Approved: LEVETIRACETAM — Original Application (Solco Healthcare US, LLC)

View source ↗

Summary

FDA approves Solco Healthcare US, LLC's generic levetiracetam through an Original Application (ANDA). The approval covers the same epilepsy indications as the b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)